Trial Profile
Tamsulosin +/- fesoterodine extended-release in men with lower urinary tract symptoms associated with benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2013
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary) ; Tamsulosin
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 24 Aug 2013 New trial record